OpenVSafe by OpenVAERS
Search V-safe

5Q7-55392-10579

3 vaccinations 2 coded responses 17 check-ins 2 free-text entries 6 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
982 / WA
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
ZQA-12793-49757 Child or adolescent in my care · Male · 2021-11-15
LG6-29921-88268 Child or adolescent in my care · Male · 2021-11-15

Timeline

  1. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-08
    Registered in v-safe
  3. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-09
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-09
    Report sent to call center — day 0, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Adult check-in
  7. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site warmth — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to work
    Free text: Red/hot at injection site today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-12
  12. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to work
    Adult check-in
  13. 2021-01-13
  14. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · None
    Adult check-in
  15. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-17
  20. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-10-19
    Dose 3 — Pfizer-BioNTech
  23. 2021-11-16
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-11-23
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-12-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-04-19
    Survey response — 6 months, dose 3
    MedDRA: Fatigue, Headache, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Exhausted, headaches, aches all over body.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-04-19
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2022-04-20
  29. 2022-10-19
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech
22021-01-09Pfizer-BioNTech
32021-10-19Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-09 Unsuccessful
2021-01-10 Unsuccessful
2021-01-11 Unsuccessful
2021-01-12 Unsuccessful
2021-01-13 Unsuccessful
2022-04-19 Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Red/hot at injection site today

Release 11 — 6 months, dose 3

2022-04-19

Symptoms: Exhausted, headaches, aches all over body.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDHeadache · · ✓
SDPain · · ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…